Compare The Coca-Cola Co K (KO) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
The Coca-Cola Co K vs Tenet Healthcare Corporation — how do they compare? The Coca-Cola Co K trades at $86.53 (market cap $373.76B), while Tenet Healthcare Corporation trades at $260.39 (market cap $20.93B). The key difference: The Coca-Cola Co K is far larger — about 17.9× Tenet Healthcare Corporation's market cap, and The Coca-Cola Co K pays a 2.44% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals.
| KO | THC | |
|---|---|---|
Market Cap | $373.76B | $20.93B |
Volume | 14,630,257 | — |
Sector | Consumer Staples | Health |
52-Week High | $89.08 | $262.63 |
52-Week Low | $65.67 | $161.37 |
Enterprise Value | $400.93B | $32.01B |
Dividend Yield | 2.44% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Coca-Cola (KO) trades at $86.48, down 0.65% on the day, with a bullish technical signal supported by moving averages and oversold RSI levels. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $0.97 exceeding the $0.92 estimate, and maintains robust profitability with a 28.56% net margin. Recent news highlights institutional buying and stable demand trends, while dividends continue with a $0.53 payout.
The outlook is positive with a consensus price target of $95.83 implying 11% upside, driven by earnings momentum and dividend reliability. Risks include regional demand volatility and high debt levels, but analyst sentiment is bullish with 60% buy ratings. The stock presents a steady growth opportunity with defensive income characteristics.
Tenet Healthcare (THC) trades at $262.13, up 2.14% with strong technical momentum and bullish analyst sentiment. The stock shows robust fundamentals with Q2 2026 EPS beating estimates at $6.12 versus $4.26 expected, while valuation metrics remain attractive with P/E of 10.05 and EV/EBITDA of 5.74. Recent institutional buying and positive earnings revisions support the upward trend.
Outlook remains positive with consensus price target of $281.44 offering 7.4% upside potential. Key risks include healthcare policy headwinds and competitive pressures, but strong ambulatory growth and expense management provide fundamental support. The stock presents a compelling value-growth combination for investors seeking healthcare exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About The Coca-Cola Co K
The Coca-Cola Company manufactures, markets, and distributes soft drink concentrates and syrups. The Company also distributes and markets juice and juice-drink products. Coca-Cola distributes its products to retailers and wholesalers in the United States and internationally.
Read more on KO →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
